Cencora

(New York Stock Exchange)
Slightly Bullish +15

Allspring Global Investments Holdings LLC Grows Stock Holdings in ...

πŸ“ˆ Allspring Global Investments Holdings LLC raised its Cencora holdings by 7.8% in Q1, adding 29,983 shares to a total position of 413,051 shares.

🏦 Multiple institutional investors including Kemnay Advisory Services Inc., Oakworth Capital Inc., and Motiv8 Investments LLC established new stakes valued between $25,000 and $29,000 in Q4.

πŸ“‰ Cencora reported Q1 EPS of $4.75, missing analyst consensus estimates of $4.82 by $0.07 per share.

πŸ’° The company generated quarterly revenue of $78.36 billion, a 3.9% increase compared to the same quarter in the prior year.

πŸ“Š Cencora achieved a return on equity of 135.20% and maintained a net margin of 0.78% during the reported quarter.

πŸ”„ The Board of Directors approved a $2.00 billion share repurchase program, allowing the purchase of up to 3.9% of outstanding shares.

πŸ’΅ Cencora paid a quarterly dividend of $0.60 per share on June 1st, offering an annualized yield of 0.8%.

πŸ‘” Director Lauren M. Tyler purchased 550 shares for $148,626.50, increasing her personal ownership by 14.44% to 4,359 shares.

πŸ“‰ Robert W. Baird reduced its price target from $420.00 to $339.00 while maintaining an 'outperform' rating.

πŸ“‰ Citigroup lowered its price target from $405.00 to $355.00 but retained a 'buy' rating for the stock.

πŸ“‰ Wells Fargo & Company cut its price objective from $429.00 to $331.00 with an 'overweight' rating.

πŸ“ˆ Bank of America increased its target price from $280.00 to $285.00 and issued a 'neutral' rating.

🎯 The consensus analyst target price for Cencora is currently set at $367.75 with an average rating of 'Moderate Buy'.

🏒 Hedge funds and other institutional investors collectively own 97.52% of the company's outstanding stock.

πŸ“ˆ Insider ownership stands at 0.38%, with Director Lauren M. Tyler holding a significant portion of that stake.

Bullish Signals
  • Allspring Global Investments Holdings LLC increased its position by 7.8% in Q1, signaling continued institutional confidence in the company.
  • Several other large investors, including Kemnay Advisory Services Inc., Oakworth Capital Inc., and Motiv8 Investments LLC, established new positions valued between $25,000 and $29,000 in Q4.
  • Archer Investment Corp significantly increased its holdings by 134.3% in Q4, demonstrating strong bullish sentiment from a specific investor.
  • Cencora approved a substantial $2.00 billion share repurchase program, indicating management's belief that the stock is undervalued and a commitment to returning capital to shareholders.
  • The company paid a quarterly dividend of $0.60 per share on June 1st, providing income to shareholders with an annualized yield of 0.8%.
  • Director Lauren M. Tyler purchased 550 shares for $148,626.50, increasing her personal ownership by 14.44%, which often signals insider confidence in the company's future prospects.
  • Cencora achieved a robust return on equity of 135.20% and maintained a positive net margin of 0.78% despite missing earnings estimates.
  • Revenue grew by 3.9% year-over-year to $78.36 billion, demonstrating consistent top-line growth in the pharmaceutical distribution sector.
Risk Factors
  • Cencora missed quarterly earnings estimates, reporting EPS of $4.75 against analyst consensus of $4.82, a miss of $0.07 per share.
  • Quarterly revenue of $78.36 billion fell short of analyst expectations of $81.09 billion, indicating potential headwinds in the distribution market.
  • Multiple major analysts reduced their price targets, with Robert W. Baird cutting from $420.00 to $339.00, Citigroup from $405.00 to $355.00, and Wells Fargo from $429.00 to $331.00.
  • The consensus analyst target price of $367.75 is significantly below the recent high price targets mentioned by analysts like Robert W. Baird ($420.00) and Citigroup ($405.00), suggesting a downward revision in valuation expectations.
Full Analysis
Allspring Global Investments Holdings LLC increased its stake in Cencora, Inc. (NYSE:COR) by 7.8% during the first quarter, acquiring an additional 29,983 shares to hold a total of 413,051 shares valued at $131.21 million. This represents a 0.21% ownership stake in the company. Several other institutional investors also adjusted their positions in the fourth quarter, with Kemnay Advisory Services Inc., Oakworth Capital Inc., Elyxium Wealth LLC, and Motiv8 Investments LLC all establishing new stakes valued between $25,000 and $29,000. Archer Investment Corp significantly increased its holdings by 134.3%, bringing its total stake to 82 shares worth $28,000. Cencora reported quarterly earnings on May 6th, posting EPS of $4.75 against analyst expectations of $4.82, resulting in a miss of $0.07 per share. The company generated revenue of $78.36 billion for the quarter, which was slightly below the estimated $81.09 billion but represented a 3.9% year-over-year increase. Key financial metrics included a return on equity of 135.20% and a net margin of 0.78%. The company has provided full-year 2026 earnings guidance ranging between $17.65 and $17.90 per share, while analysts currently anticipate an EPS of $17.79. The Board of Directors approved a new share repurchase program on May 21st, authorizing the company to buy back up to $2.00 billion in outstanding shares, which equates to approximately 3.9% of its stock. Additionally, Cencora paid a quarterly dividend of $0.60 per share on June 1st for shareholders of record as of May 15th, resulting in an annualized yield of 0.8%. Director Lauren M. Tyler also purchased 550 shares at an average price of $270.23, increasing her personal ownership by 14.44% to a total of 4,359 shares valued at over $1.17 million.